Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 1, 2012, Pages 210-216

  Lu, Ning Ning ^a   Li, Ye Xiong ^a   Wu, Run Ye ^a   Zhang, Xi Mei ^a   Wang, Wei Hu ^a   Jin, Jing ^a   Song, Yong Wen ^a   Fang, Hui ^a   Ren, Hua ^a   Wang, Shu Lian ^a   Liu, Yue Ping ^a   Liu, Xin Fan ^a   Chen, Bo ^a   Dai, Jian Rong ^a   Yu, Zi Hao ^a  

^a CANCER HOSPITAL   (China)

Author keywords

Hodgkin's lymphoma; Intensity modulated radiotherapy; Involved field radiotherapy

Indexed keywords

CHEMOTHERAPY; DOSIMETRY; ONCOLOGY; RADIOTHERAPY; TOXICITY;

COMBINATION CHEMOTHERAPY; DOSE-VOLUME HISTOGRAMS; HODGKIN'S LYMPHOMA; INTENSITY-MODULATED RADIOTHERAPY; INVOLVED FIELD RADIOTHERAPY; METHODS AND MATERIALS; PLANNING TARGET VOLUMES; PROGRESSION FREE SURVIVAL RATES;

DIAGNOSIS;

BLEOMYCIN; DACARBAZINE; DOXORUBICIN; VINBLASTINE;

ADOLESCENT; ADULT; AGED; AXILLARY LYMPH NODE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CERVICAL LYMPH NODE; DOSIMETRY; EARLY CANCER; FEMALE; HISTOGRAM; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TREATMENT OUTCOME;

EID: 84865687933     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.11.008     Document Type: Article

References (20)

1. A. Engert, J. Franklin, and H.T. Eich Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: Final results of the GHSG7 trial J Clin Oncol 25 2007 3495 3502
2. C. Ferme, E. Houchingue, and J.H. Meerwaldt Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease N Engl J Med 357 2007 1916 1927
3. A. Engert, A. Plütschow, and H.T. Eich Reduced treatment intensity in patients with early-stage Hodgkin's Lymphoma N Engl J Med 363 2010 640 652
4. H.T. Eich, V. Diehl, and H. Görgen Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: Final analysis of the German Hodgkin Study Group HD11 trial J Clin Oncol 28 2010 4199 4206
5. A.B. Chen, B.A. Neville, and D.J. Sher Survival outcomes after radiation therapy for stage III non-small cell lung cancer after adoption of computed tomography-based simulation J Clin Oncol 29 2011 2305 2311
6. C.M. Nutting, J.P. Mordan, and K.J. Harrington Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): A phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
7. H. Wang, Y.X. Li, and W.H. Wang Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiation therapy for patients with early stage nasal NK/T-cell lymphoma Int J Radiat Oncol Biol Phys 2011 Apr 20 10.1016/j.ijrobp.2011.02.039
8. K.A. Goodman, S.M.S. Toner, and M.M.S. Hunt Intensity-modulated radiotherapy for lymphoma involving the mediastinum Int J Radiat Oncol Biol Phys 62 2005 198 206
9. D.C. Weber, N. Peguret, and G. Dipasquale Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: A comparative planning study Int J Radiat Oncol Biol Phys 75 2009 1578 1586
10. B.S. Chera, C. Rodriguez, and C.G. Morris Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: Conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy Int J Radiat Oncol Biol Phys 75 2009 1173 1180
11. A. Paumier, M. Ghalibafian, and A. Beaudre Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma Int J Radiat Oncol Biol Phys 80 2011 199 205
12. J. Yahalom, and P. Mauch The involved field is back: Issues in delineating radiation field in Hodgkin's disease Ann Oncol 13 Suppl. 1 2002 79 83
13. B.D. Cheson, S.J. Horning, and B. Coiffier Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas J Clin Oncol 17 1999 1244 1253
14. S.L. Wang, Z.X. Liao, and X. Wei Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT) Int J Radiat Oncol Biol Phys 66 2006 1399 1407
15. E.D. Yorke, A. Jackson, and K.E. Rosenzweig Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study Int J Radiat Oncol Biol Phys 63 2005 672 682
16. E.S. Koh, A. Sun, and T.H. Tran Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma Int J Radiat Oncol Biol Phys 66 2006 223 228
17. T. Girinsky, R. vander Maazen, and L. Specht Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: Concepts and guidelines Radiother Oncol 79 2006 270 277
18. R.A. Campbell, N. Voss, and T. Pickles Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: A question of field size J Clin Oncol 26 2008 5170 5174
19. M.M. O'Brien, S.S. Donaldson, and R.R. Balise Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemothrapy J Clin Oncol 28 2010 1232 1239
20. S.L. Galper, J.B. Yu, and P.M. Mauch Clinically significant cardiac disease in patients with Hodgkin lymphoma treated with mediastinal irradiation Blood 117 2011 412 418